Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCU
2701
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $4.14M | ﹤0.01% |
187,212
-6,166
| -3% | -$114K |
|
|
REVG
2702
DELISTED
REV Group
REVG
| $4.13M | ﹤0.01% |
337,918
-1,637
| -0.5% | -$20.7K |
|
2703
Metropolitan Bank Holding Corp
MCB
$1.17B
| $4.12M | ﹤0.01% |
85,332
-696
| -0.8% | -$30.7K |
|
|
EXPR
2704
DELISTED
Express, Inc.
EXPR
| $4.1M | ﹤0.01% |
42,120
-2,291
| -5% | -$180K |
|
|
LVGO
2705
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $4.09M | ﹤0.01% |
163,147
+1,191
| +0.7% | +$28.5K |
|
2706
Forestar Group
FOR
$1.51B
| $4.07M | ﹤0.01% |
195,338
+35,532
| +22% | +$694K |
|
2707
FlexShares Developed Markets ex-US Quality Low Volatility Index Fund
QLVD
$55.4M
| $4.06M | ﹤0.01% |
+154,491
| New | +$3.97M |
|
2708
Teekay
TK
$1.06B
| $4.05M | ﹤0.01% |
761,109
-54,411
| -7% | -$269K |
|
|
PTR
2709
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $4.05M | ﹤0.01% |
80,390
-110,089
| -58% | -$5.42M |
|
2710
Arbor Realty Trust
ABR
$981M
| $4.04M | ﹤0.01% |
281,413
+43,677
| +18% | +$621K |
|
2711
Citizens
CIA
$198M
| $4.03M | ﹤0.01% |
596,694
-9,032
| -1% | -$62.1K |
|
2712
Caesarstone
CSTE
$105M
| $4.02M | ﹤0.01% |
266,836
+5,333
| +2% | +$85.6K |
|
2713
Nice
NICE
$6.17B
| $4.02M | ﹤0.01% |
25,900
-147
| -0.6% | -$22.4K |
|
|
BCOV
2714
DELISTED
Brightcove, Inc.
BCOV
| $4.01M | ﹤0.01% |
461,623
+1,188
| +0.3% | +$11.2K |
|
2715
Goldgroup Mining Inc.
GORO
$211M
| $4.01M | ﹤0.01% |
723,516
-37,966
| -5% | -$166K |
|
2716
Health Catalyst
HCAT
$132M
| $4.01M | ﹤0.01% |
115,452
+7,070
| +7% | +$234K |
|
|
IVC
2717
DELISTED
Invacare Corporation
IVC
| $3.98M | ﹤0.01% |
441,112
-17,125
| -4% | -$144K |
|
|
CHNG
2718
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $3.97M | ﹤0.01% |
242,044
+14,677
| +6% | +$197K |
|
2719
Vanguard FTSE Pacific ETF
VPL
$8.65B
| $3.96M | ﹤0.01% |
56,913
+3,160
| +6% | +$217K |
|
|
ORBC
2720
DELISTED
ORBCOMM, Inc.
ORBC
| $3.95M | ﹤0.01% |
938,471
-267,586
| -22% | -$1.14M |
|
2721
A10 Networks
ATEN
$1.96B
| $3.95M | ﹤0.01% |
574,849
-86,128
| -13% | -$579K |
|
2722
Citizens & Northern Corp
CZNC
$466M
| $3.95M | ﹤0.01% |
139,679
-3,927
| -3% | -$102K |
|
|
VRAY
2723
DELISTED
ViewRay, Inc.
VRAY
| $3.94M | ﹤0.01% |
933,135
-109,824
| -11% | -$355K |
|
2724
Woori Financial
WF
$17.2B
| $3.93M | ﹤0.01% |
129,933
-1,526
| -1% | -$46.7K |
|
2725
Quanterix
QTRX
$135M
| $3.92M | ﹤0.01% |
166,012
-10,803
| -6% | -$247K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.